In 2023, 32.69 per cent of adults in Canada (10.6 million people) were overweight with a Body-Mass Index (BMI) of 30 or ...

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Consumers are becoming more concerned about their health, with many prioritising weight loss. But what do they consider to be ...

For Immediate Release Chicago, IL – July 10, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog.

SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that human study GLP-1-H25-5 which ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially ...

I am sorry, but it is very likely that the cancer has come back somewhere in your body. However, this is not 100 per cent ...

Then on April 28, it elevated to 29.3 ng/mL, at which time my oncologist prescribed an ... DEAR DR. ROACH: I have three ...